Gut bug tied to fatty liver? scientists launch probe
NCT ID NCT07455149
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will examine whether a specific gut bacterium, Ruminococcus gnavus, and the chemicals it produces are linked to metabolic dysfunction-associated fatty liver disease (MAFLD). Researchers will compare 200 healthy adults and those with MAFLD to understand the connection. No treatments or interventions are given; this is purely an observational study to gather knowledge.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a quick liver scan replace needle biopsies for MASH in diabetics?
- Mushroom supplement shows promise for fatty liver in new trial
- Stomach bug linked to fatty liver? new study investigates
- Amino acid supplement may help fatty liver – new study
- Which supplement cuts liver fat best? new trial aims to find out.
- Home HIIT bike workout targets fatty liver in new trial